New drug shows promise for irreversible hair loss
Disease control
Completed
This study tested an experimental drug (a JAK/TYK2 inhibitor) in 51 adults with cicatricial alopecia, a type of scarring hair loss that destroys hair follicles permanently. The main goals were to check the drug's safety and to see how it affects certain genes in skin and blood sa…
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated May 22, 2026 14:02 UTC